Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.34 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7928918 | 0.95 | CYP2C19 (0.39) | CYP2C19CYP3A4MEN1KMT2ACYP2D6 | |
| SCHEMBL2728151 | 0.93 | ALDH1A1 (0.38) | CYP2C19CYP3A4MEN1KMT2ACYP2D6 | |
| SCHEMBL19841985 | 0.84 | OPRM1 (0.46) | CYP2C19CYP3A4OPRM1OPRD1OPRK1 | |
| SCHEMBL16925425 | 0.81 | OPRM1 (0.47) | CYP2C19CYP3A4MEN1KMT2APOLB | |
| SCHEMBL9583303 | 0.80 | TSHR (0.39) | CYP2C19CYP3A4MEN1KMT2ACYP2D6 | |
| SCHEMBL16925439 | 0.80 | OPRM1 (0.40) | CYP2C19CYP3A4MEN1KMT2APOLB | |
| SCHEMBL16925440 | 0.79 | OPRM1 (0.41) | OPRM1OPRD1OPRK1SLC22A1SLC6A4 | |
| SCHEMBL27123245 | 0.78 | CYP2C19 (0.39) | CYP2C19CYP3A4MEN1KMT2ACYP2D6 | |
| SCHEMBL1971303 | 0.77 | OPRM1 (0.38) | CYP2C19CYP3A4MEN1KMT2ACYP2D6 | |
| SCHEMBL19842011 | 0.77 | OPRM1 (0.40) | MEN1KMT2AOPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795138-B2 | Process of fluorinating inorganic compounds by direct fluorination | Fujian Yongjing Technology Co.,Ltd (CN) | 2023-10-24 | — | — | US | disclosed |
| US-11795138-B2 | Process of fluorinating inorganic compounds by direct fluorination | Fujian Yongjing Technology Co.,Ltd (CN) | 2023-10-24 | — | — | US | disclosed |
| US-20220135516-A1 | Process of Fluorinating Inorganic Compounds by Direct Fluorination | Fujian Yongjing Technology Co.,Ltd (CN) | 2022-05-05 | — | — | US | disclosed |
| WO-2021031432-A1 | PROCESS OF FLUORINATING INORGANIC OR ORGANIC COMPOUNDS BY DIRECT FLUORINATION | FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) | 2021-02-25 | — | — | WO | disclosed |
| US-20210053911-A1 | Process of Fluorinating Inorganic or Organic Compounds by Direct Fluorination | FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) | 2021-02-25 | — | — | US | disclosed |
| US-20090048203-A1 | SUBSTITUTED ADENINES AND THE USES THEREOF | ASTRAZENECA AB (SE) | 2009-02-19 | — | — | US | disclosed |
| EP-1805196-A1 | SUBSTITUTED ADENINES AND THE USE THEREOF | AstraZeneca AB (SE) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006040558-A1 | SUBSTITUTED ADENINES AND THE USE THEREOF | ASTRAZENECA AB (SE) | 2006-04-20 | — | — | WO | disclosed |
| US-20050075501-A1 | Ammonium compounds bearing and electrophilic fluorine, reagent containing same, method using same and synthesis method for obtaining them | RHODIA CHIMIE (FR) | 2005-04-07 | — | — | US | disclosed |
| EP-0526849-B1 | Substituted N-Fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof | DAIKIN IND LTD (JP) | 1999-12-01 | — | — | EP | disclosed |
| US-5614626-A | 1,2,3-Oxathiazin-4(3F)-one 2,2-dioxides, a process for their preparation and their use as electrophilic fluorinating agents | HOECHST AG (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5374732-A | Chemical intermediates as fluorination agents | DAIKIN INDUSTRIES, LTD. (JP) | 1994-12-20 | — | — | US | disclosed |
| EP-0526849-A1 | Novel substituted N-Fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof | DAIKIN INDUSTRIES, LTD. (JP) | 1993-02-10 | — | — | EP | disclosed |
| US-5003074-A | N-fluorinated sulfonamides | CIBA-GEIGY CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| EP-0311086-A1 | N-fluorinated sulfon amides, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1989-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795138-B2 | Process of fluorinating inorganic compounds by direct fluorination | AFF2, CYP4F2, AFF1 | CYP2C19 59/4885CYP3A4 22/4885MEN1 1377/4885 |
| US-20090048203-A1 | SUBSTITUTED ADENINES AND THE USES THEREOF | HPRT1, APRT, NUDT1 | CYP2C19 337/4885CYP3A4 889/4885MEN1 2161/4885 |
| US-20210053911-A1 | Process of Fluorinating Inorganic or Organic Compounds by Direct Fluorination | CYP4F2, AFF2, CYP4F3 | CYP2C19 57/4885CYP3A4 18/4885MEN1 1888/4885 |
| US-20220135516-A1 | Process of Fluorinating Inorganic Compounds by Direct Fluorination | AFF2, CYP4F2, AFF1 | CYP2C19 59/4885CYP3A4 22/4885MEN1 1377/4885 |
| US-20050075501-A1 | Ammonium compounds bearing and electrophilic fluorine, reagent containing same, method using same and synthesis method for obtaining them | ARF5, AFF2, ARFGEF1 | CYP2C19 1409/4885CYP3A4 1055/4885MEN1 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.